Award details

Where is the initial site of folic acid biotransformation in humans?

Reference	BB/F014457/1
Principal Investigator / Supervisor	Mr Paul Finglas
Co-Investigators / Co-Supervisors	Mr Anthony Wright
Institution	Quadram Institute Bioscience
Department	Food Databanks National Capability
Funding type	Research
Value (£)	244,793
Status	Completed
Type	Research Grant
Start date	01/07/2008
End date	30/06/2011
Duration	36 months

Abstract

The importance of adequate folate intake to public health is underlined by evidence that neural tube defects can be prevented by periconceptional intake of supplemental folic acid, as well as epidemiological evidence linking the prevalence of other major diseases to poor folate intake and status. We will address whether folic acid is absorbed by the intestinal mucosa and transferred to the hepatic portal vein in an unmetabolised state in contrast to naturally-occurring folates such as 5-formyltetrahydrofolic acid. Expertise in mathematical estimation of folate absorption in humans will be combined with the recent availability of hepatic portal vein (HPV) cannulated patients in Newcastle (uniquely in the UK) as a potential model of 'normal' human intestinal and liver function. The analytical expertise will be provided by Nottingham in the use of a newly developed and validated LC-MS-MS procedure for folate profiling in biological samples. Two human studies are planned (Newcastle using HPV patients and Norwich using healthy volunteers). Results from the Norwich Study, which will involve estimation of the inherently accessible plasma-pool volume -of-distribution, will be used to assist in estimation of the the amount of test folates (or their biotransformed counterparts) entering the systemic circulation in the Newcastle Studies. These findings would enable a more informed risk assessment to be conducted at a population level to decide whether food fortification with folic acid might lead to undesirable levels of this synthetic compound in the blood.

Summary

The importance of adequate folate intake to public health is underlined by evidence that neural tube defects can be prevented by intake of supplemental folic acid before conception, as well as epidemiological evidence linking the prevalence of other major diseases to poor folate intake and status. The UK Government is currently considering the mandatory folic acid fortification of flour in the UK in order to help reduce the risk of neural tube defects (such as spina bifida) in unborn babies. The suggested fortification level of 300mcg/100g is two-fold higher than being used in the USA, where there has already been reports of high concentrations of unmetabolised folic acid in the systemic plasma circulation in US citizens. This has raised some concerns, not merely from the potential masking of vitamin B12 deficiency in the elderly but deleterious affects on folate gene expression such as a potential upregulation of folate enzymes that are current targets for anti-folate chemotherapy (e.g. dihydrofolate reductase, DHFR). Moreover, there are current question maks regarding its potential to accelerate cognitive decline in B12-deficient elderly, to accelerate the rate and extent of coronary in-stent restenosis, increase multiple births after invitro-fertilisation treatment, to affect immune function, ito ncrease risk of multiple colorectal adenomas, and to increase incidence of breast cancer in post-menopausal women. The proposed collaboration between IFR, and the Universities of Newcastle and Nottingham in the current proposal will provide an innovative and timely opportunity to develop a better fundemental understanding of the process of absorption and site of initial biotransformation of physiological doses of folic acid using new data from hepatic portal vein (HPV) cannulated patients in Newcastle (uniquely in the UK) as a potential model of 'normal' human intestinal and liver function. This exceptional opportunity is likely to be short-lived because of the increasing introduction of TIPSS Doppler monitoring in these patients rather than catheterisation, making this type of study extremely difficult to justify ethically. The project overall provides a unique opportunity not only to verify whether folic acid is transported to the liver in an unmetabolised state but also enhancing our understanding of in vivo folate kinetics in humans. These findings would enable a more informed risk assessment to be conducted at a population level to decide whether food fortification with folic acid might lead to undesirable levels of this synthetic compound in the blood. The findings will be of immediate use to the ongoing debate regarding folic acid fortification of flour, and also to the food industry in developing alternate folate enriched foods.

Committee	Closed Committee - Agri-food (AF)
Research Topics	Diet and Health
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

Associated awards:

BB/F012594/1 Where is the initial site of folic acid biotransformation in humans?

BB/F014104/1 Where is the Initial Site of Folic Acid Biotransformation in Humans?

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search